The complexity of growth failure in children receiving tyrosine kinase inhibitor therapy for chronic myelogenous leukemia

Jill Hibishman Samis*, Paul Lee, Donald Zimmerman, Meinolf Suttorp, Nobuko Hijiya

*Corresponding author for this work

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish (US)
Article numbere26703
JournalPediatric Blood and Cancer
Volume64
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Growth
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

@article{ff144b3eefd44657a719ec6d654992c7,
title = "The complexity of growth failure in children receiving tyrosine kinase inhibitor therapy for chronic myelogenous leukemia",
author = "Samis, {Jill Hibishman} and Paul Lee and Donald Zimmerman and Meinolf Suttorp and Nobuko Hijiya",
year = "2017",
month = "12",
day = "1",
doi = "10.1002/pbc.26703",
language = "English (US)",
volume = "64",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "12",

}

The complexity of growth failure in children receiving tyrosine kinase inhibitor therapy for chronic myelogenous leukemia. / Samis, Jill Hibishman; Lee, Paul; Zimmerman, Donald; Suttorp, Meinolf; Hijiya, Nobuko.

In: Pediatric Blood and Cancer, Vol. 64, No. 12, e26703, 01.12.2017.

Research output: Contribution to journalLetter

TY - JOUR

T1 - The complexity of growth failure in children receiving tyrosine kinase inhibitor therapy for chronic myelogenous leukemia

AU - Samis, Jill Hibishman

AU - Lee, Paul

AU - Zimmerman, Donald

AU - Suttorp, Meinolf

AU - Hijiya, Nobuko

PY - 2017/12/1

Y1 - 2017/12/1

UR - http://www.scopus.com/inward/record.url?scp=85023167291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023167291&partnerID=8YFLogxK

U2 - 10.1002/pbc.26703

DO - 10.1002/pbc.26703

M3 - Letter

C2 - 28696050

AN - SCOPUS:85023167291

VL - 64

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 12

M1 - e26703

ER -